Catalyst Capital Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-417	Closed	-$114K	–	454
2014 Q4	$114K	Buy	+417	New	+$114K	0.01%	312